Could Investors Overdose on Pharmaceuticals? More than 12 billion coronavirus vaccine doses have been administered. There are, however, alternatives. 4 MIN READ 09.11.2022
Time To Reconsider Galapagos as New CEO Paul Stoffels Named Stoffels will succeed CEO and co-founder Onno van de Stolpe, following his planned retirement. 2 MIN READ 01.27.2022
FDA Authorizes Roche’s Arthritis Drug Actemra for Emergency Use To Treat Severe COVID-19 Studies showed Actemra (tocilizumab) helped reduce risk of death and speed recovery in hospitalized patients. 2 MIN READ 06.25.2021
Gilead Beats Fourth Quarter Estimates, Provides Upbeat Forecast for 2021 Remdesivir, sold under the brand name Veklury, brought in $1.9 billion in the fourth quarter ended Dec. 31. 2 MIN READ 02.5.2021
Gilead Raises Full-Year Profit Forecast on Increased Demand for Antiviral Remdesivir Adjusted earnings are now projected to be $6.98-$7.08 per share, up from the previously forecast range of $6.25-$6.60. 1 MIN READ 01.11.2021
Global Health Experts Clash Over Use of Certain Drugs for COVID-19 Patients The disagreements have led to different treatment options for patients depending on where they live. 4 MIN READ 11.20.2020
